Physiology or Medicine · announced Monday, 6 October 2025
The cells that keep the body from attacking itself
“for their discoveries concerning peripheral immune tolerance”
- Mary E. Brunkow b. 1961 · Institute for Systems Biology, Seattle
- Fred Ramsdell b. 1960 · Sonoma Biotherapeutics, San Francisco
- Shimon Sakaguchi b. 1951 · Osaka University
In plain terms
The immune system has to attack thousands of kinds of microbe, many of which have come to look like human cells, and still leave the body’s own tissues alone. Its T cells carry receptors made by shuffling genes at random, so some are bound to recognise the body itself. By the 1980s researchers knew that most of these are weeded out in the thymus before they mature. Many thought that was the whole answer. An older idea, that special “suppressor” cells kept the rest in check, had collapsed when some of the evidence for it proved false.
Shimon Sakaguchi kept working on it. Colleagues had found that mice whose thymus was removed three days after birth developed autoimmune diseases, and that cells from healthy mice could prevent them. In 1995, after more than a decade, Sakaguchi identified the protective cells: a class of T cells marked by a protein called CD25, now called regulatory T cells. Separately, Mary Brunkow and Fred Ramsdell, at a biotech company near Seattle, hunted for the mutation behind the scurfy mouse, a strain whose males die within weeks as their own T cells destroy their organs. In 2001 they found it in a new gene, which they named Foxp3, and showed that faults in the human version cause IPEX, a rare and severe autoimmune disease of boys. In 2003 Sakaguchi showed that Foxp3 is what makes a regulatory T cell.
These cells patrol the body’s tissues and restrain other immune cells, and they calm the immune response once an infection is cleared. Without them the body attacks itself. Researchers are now testing ways to add more of them, against autoimmune disease and transplant rejection, and ways to remove them from tumours, which use them as a shield. In June 2026 a treatment built on purified regulatory T cells, the first of its kind according to its maker, was approved in the United States for patients having stem-cell transplants for blood cancers. Most other uses are still in trials.
- 1940s
- At Oak Ridge, Tennessee, in a laboratory studying radiation for the Manhattan Project, male mice are born with flaky skin and swollen glands and live only a few weeks. The strain is named scurfy.
- 1982
- Sakaguchi and Yasuaki Nishizuka show that a fraction of immune cells from normal mice can stop the autoimmune disease that follows removal of the thymus.
- 1995
- After more than a decade’s work, Sakaguchi defines regulatory T cells by the marker CD25. Many colleagues remain sceptical.
- 2001
- Brunkow and Ramsdell find the scurfy mutation in a new gene, Foxp3, and show that mutations in the human gene cause IPEX.
- 2003
- Sakaguchi shows that Foxp3 governs the development of regulatory T cells. Ramsdell’s group and Alexander Rudensky’s publish supporting results the same year.
- 2025
- The prize. Brunkow saw a Swedish number at night, took it for spam, and went back to sleep. Ramsdell, on a three-week hike with his phone in airplane mode, heard the news from his wife when they came back into signal in Montana.
- 2026
- In June the FDA approves Orca-T, a transplant product containing purified regulatory T cells, to reduce graft-versus-host disease in adults with blood cancers. Treatments for autoimmune disease are still in early trials.
Say it accurately
- “They discovered how the body learns not to attack itself.”
- Immune tolerance itself was recognised long before: Burnet and Medawar won the 1960 prize for it, and the weeding out of self-attacking T cells in the thymus, called central tolerance, was worked out in the 1980s. This prize is for a second safeguard that works out in the body’s tissues, the regulatory T cell. The committee’s background paper names others who contributed, among them Nishizuka, Fiona Powrie, Ethan Shevach and Alexander Rudensky.
- “A cure for autoimmune disease is coming.”
- The committee speaks of hope and of treatments now being tested in clinical trials. The one approval so far, in June 2026, is for transplant patients with blood cancers, where purified regulatory T cells lower the risk that donor cells attack the patient. For autoimmune disease the work is early. A trial in rheumatoid arthritis run by Ramsdell’s company, for instance, reported its first results from a phase 1 study in six patients.
- “Autoimmune disease is the body sinning against itself,” or “the immune system attacking the body is like sin.”
- An immune cell has no will. The boys with IPEX are ill because a gene is damaged, not because anyone has done wrong, and the same goes for anyone living with an autoimmune disease. The image may be borrowed for a sermon on how Christians treat one another. It must not be turned back on the sick.
- “The science shows that tolerance is always good.”
- In immunology tolerance means not attacking one’s own tissues. It is not the virtue of bearing with people who differ. And immune restraint can do harm: tumours draw in large numbers of regulatory T cells to shield themselves, and some cancer treatments under test aim to remove them. Health is the right attack on the right target, not the least attack.
- “They found the gene for autoimmune disease.”
- Foxp3 is the gene a regulatory T cell needs in order to be one. When it is broken, as in the rare inherited disease IPEX, the whole system breaks down. That shows how much depends on these cells. It does not mean that common autoimmune diseases come from a faulty Foxp3.
For preaching
-
“Ours, at least, can explain what we saw” Instance
1 Thessalonians 5:21 · Proverbs 18:17
When the evidence for “suppressor T cells” partly proved false, the field abandoned the whole idea. Sakaguchi kept to a result he had seen himself, that normal T cells could stop a disease. Each time a new theory appeared, he said, “we checked which one is better, our idea or theirs.” He neither clung to the idea blindly nor dropped it because it was out of fashion. Paul is speaking of prophecy, but his rule is general: “Test all things, and hold firmly that which is good” (1 Thessalonians 5:21, WEB).
-
The twentieth gene Instance
Ecclesiastes 9:10 · Galatians 6:9
Brunkow and Ramsdell narrowed the scurfy mutation to a stretch of DNA holding about twenty genes, and checked them one by one. It was the last of the twenty. Brunkow called it “a molecular slog.” She has since left the field, and called the work “an amazing team effort.” “Whatever your hand finds to do, do it with your might” (Ecclesiastes 9:10, WEB).
-
If you bite and devour one another Likeness
Galatians 5:13–15 · 1 Corinthians 12:21–26
Without its regulatory T cells, a body’s defences turn on its own organs, and the scurfy mice lived only a few weeks. Paul warns a church of the same outcome: “if you bite and devour one another, be careful that you don’t consume one another” (Galatians 5:15, WEB). The picture proves nothing about churches. It also fails at a point a preacher must state aloud: the immune system has no choice, and the people of Galatia did.
-
Strength held in check Likeness
Proverbs 16:32 · Galatians 5:22–23 · James 1:19–20
Regulatory T cells do not weaken the immune system. They hold it back from the wrong target, and calm it once an invader is gone, so that a strong defence does not become a danger. “One who is slow to anger is better than the mighty; one who rules his spirit, than he who takes a city” (Proverbs 16:32, WEB). Use it as a picture of self-control. The cells exercise no virtue, and the fruit of the Spirit is not a mechanism.
On the Wesleyan shelf
-
On Zeal (sermon on Galatians 4:18)
Wesley takes a force that is good and needed and asks what keeps it from doing harm. Zeal, he says, is “not properly religious or Christian zeal, if it be not joined with charity” (§I.2); it is “no other than the flame of love” (§I.3). So “every sort of bitterness toward them that oppose us” is “directly opposite to it” (§III.1), and as for those “who call their anger by that name,” they “put darkness for light, and light for darkness” (§III.3). His subject is the soul, not the body. But a sermon on this prize can borrow the shape of his argument: the defender that will not be governed becomes the attacker.
-
A Caution against Bigotry (sermon on Mark 9:38–39)
The committee notes that harmful microbes “do not wear a uniform,” so the immune system must judge friend from foe some other way. Wesley’s sermon is about the same mistake among Christians: forbidding one who does Christ’s work “because he followeth not us.” He warns how “unwilling men are to allow anything good in those who do not in all things agree with themselves” (§III.2), and defines the bigot as one so attached to his own “party, opinion, church, and religion” that he forbids such a man (§IV.1). His test is the fruit, not the badge. The parallel is a likeness only; Wesley argues from Scripture and from what can be seen, not from the body.
-
On the Fall of Man (sermon on Genesis 3:19)
Wesley marvels at the body as “fearfully and wonderfully wrought”, its parts mixed “in the most exact proportion; so that while the body is in health, no one of them predominates” (§II.1). In the present state of things, though, the embodied mind misjudges: “I mistake, and possibly cannot avoid mistaking the character of this or that man. I suppose him to be what he is not” (§II.2), a mistake “occasioned by the defect of my bodily organs.” His physiology of elements is long gone. His sense that health is a balance, and that an embodied creature can take a friend for an enemy and “possibly cannot avoid” it, sits well beside this prize. The immune system is a picture of his point, not a proof of it.
Sources: Nobel press release · Nobel popular information · Nobel scientific background (pdf) · Nobel telephone interview with Shimon Sakaguchi · Nobel telephone interview with Mary Brunkow · Phys.org (AFP) on Fred Ramsdell · PharmaTimes on the phase 1 rheumatoid arthritis trial · AJMC on the FDA approval of Orca-T